Moleculin Biotech, Inc. (MBRX)
0.7646
+0.01
(+1.93%)
USD |
NASDAQ |
Sep 09, 13:07
Moleculin Biotech Market Cap : 5.429M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 5.326M |
| September 04, 2026 | 5.040M |
| September 03, 2026 | 4.796M |
| September 02, 2026 | 4.927M |
| September 01, 2026 | 4.615M |
| August 31, 2026 | 4.577M |
| August 28, 2026 | 4.614M |
| August 27, 2026 | 4.890M |
| August 26, 2026 | 4.26M |
| August 25, 2026 | 4.338M |
| August 24, 2026 | 4.326M |
| August 21, 2026 | 4.210M |
| August 20, 2026 | 4.193M |
| August 19, 2026 | 4.061M |
| August 18, 2026 | 4.332M |
| August 17, 2026 | 4.310M |
| August 14, 2026 | 4.347M |
| August 13, 2026 | 4.056M |
| August 12, 2026 | 3.708M |
| August 11, 2026 | 3.160M |
| August 10, 2026 | 2.297M |
| August 07, 2026 | 2.185M |
| August 06, 2026 | 2.054M |
| August 05, 2026 | 2.081M |
| August 04, 2026 | 2.185M |
| Date | Value |
|---|---|
| August 03, 2026 | 2.268M |
| July 31, 2026 | 2.135M |
| July 30, 2026 | 5.443M |
| July 29, 2026 | 7.258M |
| July 28, 2026 | 11.69M |
| July 27, 2026 | 11.69M |
| July 24, 2026 | 11.31M |
| July 23, 2026 | 11.10M |
| July 22, 2026 | 11.21M |
| July 21, 2026 | 11.47M |
| July 20, 2026 | 11.42M |
| July 17, 2026 | 11.21M |
| July 16, 2026 | 11.58M |
| July 15, 2026 | 12.33M |
| July 14, 2026 | 12.06M |
| July 13, 2026 | 11.79M |
| July 10, 2026 | 12.17M |
| July 09, 2026 | 13.02M |
| July 08, 2026 | 12.65M |
| July 07, 2026 | 12.38M |
| July 06, 2026 | 12.81M |
| July 02, 2026 | 14.09M |
| July 01, 2026 | 14.35M |
| June 30, 2026 | 14.89M |
| June 29, 2026 | 19.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.785B |
| Alnylam Pharmaceuticals, Inc. | 34.14B |
| Anika Therapeutics, Inc. | 279.97M |
| Savara, Inc. | 1.108B |
| Vericel Corp. | 1.991B |
Market Cap Related Metrics
| Price to Book Value | 0.4685 |
| Price | 0.7646 |
| Earnings Yield | -2.24K% |